Publicação
Pairs trade in the pharmaceutical i ndustry
| authorProfile.email | teresadinizdfonseca@gmail.com | |
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | |
| dc.contributor.advisor | Anjos, Fernando | |
| dc.contributor.author | Fonseca, Maria Teresa Maia Gonçalves e Diniz da | |
| dc.date.accessioned | 2026-06-22T11:26:29Z | |
| dc.date.available | 2026-06-22T11:26:29Z | |
| dc.date.issued | 2024-01-10 | |
| dc.date.submitted | 2023-12-20 | |
| dc.description.abstract | Investing in pharmaceutics presents lucrative opportunities, with high profit margins, due to patent exclusivity, substantial investments in R&D, robust M&A activity and relatively stable demand, even in economic downturns. The pharmaceutical industry experienced a boost in revenues due to its response to Covid-19. However, as the pandemic has subsided, sales have drastically decreased. Drug patents approaching the end of their exclusivity represent another issue to be dealt with. Nonetheless, industry’s sales are predicted to rise given unmet medical needs and population’s continuous growth, contributing to the industry’s appeal for careful analysis and investment consideration, such as a pairs trade investment strategy. | eng |
| dc.identifier.tid | 203681029 | |
| dc.identifier.uri | http://hdl.handle.net/10362/203975 | |
| dc.language.iso | eng | |
| dc.relation | UID/ECO/00124/2013 | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Valuation | |
| dc.subject | Terminal value | |
| dc.subject | Price target | |
| dc.subject | Investment strategy | |
| dc.subject | Pharmaceutical industry | |
| dc.subject | Performance | |
| dc.subject | Market analysis | |
| dc.title | Pairs trade in the pharmaceutical i ndustry | eng |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Master’s degree in Finance from the Nova School of Business and Economics |